Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Bingquan, Jian"'
Autor:
Weijian Zhang, Hao Xiong, Jiaqi Pang, Lan Lai, Zhongwu Su, Hanqing Lin, Bingquan Jian, Haidi Yang, Yiqing Zheng
Publikováno v:
Journal of Bio-X Research, Vol 2, Iss 2, Pp 81-86 (2019)
Abstract. Cisplatin (CDDP)-induced ototoxicity is one of the common adverse effects of cisplatin chemotherapy. Thus far, effective approaches for attenuating hearing loss are unavailable in clinical practice. Mitochondrial biogenesis acts as a master
Externí odkaz:
https://doaj.org/article/aacfa074db0842e6862ef2990df0f581
Autor:
Hanqing Lin, Hao Xiong, Zhongwu Su, Jiaqi Pang, Lan Lai, Huasong Zhang, Bingquan Jian, Weijian Zhang, Yiqing Zheng
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 13 (2019)
Background: Mitochondrial dysfunction is considered to contribute to the development of age-related hearing loss (AHL). The regulation of mitochondrial function requires mitochondrial quality control, which includes mitophagy and dynamics. Dynamin-re
Externí odkaz:
https://doaj.org/article/9ddb56e792cf467790c0b4a53084b9f6
Autor:
Yiqing Zheng, Yongyi Ye, Haidi Yang, Ting Zhan, Wuhui He, Xin Min, Xiaotong Huang, Jiaqi Pang, Hao Xiong, Weijian Zhang, Feinan He, Zhengrong Liang, Bingquan Jian, Yiming Gao
Publikováno v:
Toxicology Letters. 349:115-123
Cisplatin, the most widely used platinum-based anticancer drug, often causes progressive and irreversible sensorineural hearing loss in cancer patients. However, the precise mechanism underlying cisplatin-associated ototoxicity is still unclear. Nico
Autor:
Hao Xiong, Yiqing Zheng, Hanqing Lin, Bingquan Jian, Zhongwu Su, Haidi Yang, Weijian Zhang, Jiaqi Pang, Lan Lai
Publikováno v:
Journal of Bio-X Research, Vol 2, Iss 2, Pp 81-86 (2019)
Cisplatin (CDDP)-induced ototoxicity is one of the common adverse effects of cisplatin chemotherapy. Thus far, effective approaches for attenuating hearing loss are unavailable in clinical practice. Mitochondrial biogenesis acts as a master element o
Autor:
Ting, Zhan, Hao, Xiong, Jiaqi, Pang, Weijian, Zhang, Yongyi, Ye, Zhengrong, Liang, Xiaotong, Huang, Feinan, He, Bingquan, Jian, Wuhui, He, Yiming, Gao, Xin, Min, Yiqing, Zheng, Haidi, Yang
Publikováno v:
Toxicology letters. 349
Cisplatin, the most widely used platinum-based anticancer drug, often causes progressive and irreversible sensorineural hearing loss in cancer patients. However, the precise mechanism underlying cisplatin-associated ototoxicity is still unclear. Nico
Autor:
Bingquan Jian, Ting Zhan, Wuhui He, Zhongwu Su, Yiqing Zheng, Huasong Zhang, Weijian Zhang, Hanqing Lin, Jiaqi Pang, Hao Xiong
Publikováno v:
Toxicology letters. 350
Cisplatin-induced hearing loss is a common side effect of cisplatin chemotherapy, for which clinical therapy remains unavailable. Apoptosis of hair cells is considered the primary cause of cisplatin-induced ototoxicity; however, inhibiting apoptosis